Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2010. The document serves as a notification to the U.S. Securities and Exchange Commission regarding a major change in shareholding interest reported by Legal & General Group Plc (L&G) to the UK Financial Services Authority.
Key Financial Metrics
The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory notification regarding voting rights and share ownership thresholds.
Material Changes
The primary material change reported is a reduction in the voting interest held by Legal & General Group Plc (L&G) in GSK:
- Threshold Change: L&G's voting interest decreased from 4% to 3%.
- Transaction Date: August 16, 2010.
- Notification Date: August 17, 2010.
- Shareholding Details: Following the transaction, L&G held 207,246,143 ordinary shares (25p), representing 3.99% of the total voting rights (based on a total of 5,192,669,600 voting rights).
- Instrument Type: The change resulted from an acquisition or disposal of voting rights attached to existing shares.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is limited to the statutory disclosure of the change in major shareholding.
Investor Verification Checklist
- Verify the total number of voting rights outstanding (5,192,669,600) to confirm the 3.99% calculation.
- Confirm the specific entities within the Legal & General Group (e.g., Legal & General Assurance (Pensions Management) Limited) holding the shares.
- Review subsequent filings to determine if the 3% threshold triggers further reporting obligations or if the stake changes again.
- Note that this filing does not reflect GSK's operational or financial performance for the period.